logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 2
  • 1
    Parsi, Amir Mehdy Negahban
    Born in July 1978
    Individual (15 offsprings)
    Officer
    2013-03-28 ~ now
    OF - Director → CIF 0
    Mr Amir Mehdy Negahban Parsi
    Born in July 1978
    Individual (15 offsprings)
    Person with significant control
    2017-03-28 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
  • 2
    Negamban Parsi, Catherine Ann
    Born in April 1981
    Individual (8 offsprings)
    Officer
    2021-02-10 ~ now
    OF - Director → CIF 0
    Parsi, Catherine Ann
    Director born in April 1981
    Individual (8 offsprings)
    Officer
    2013-06-27 ~ 2019-09-22
    OF - Director → CIF 0
parent relation
Company in focus

ALPHA PHARMACEUTICALS LTD

Period: 2019-07-18 ~ now
Company number: 08467144
Registered names
ALPHA PHARMACEUTICALS LTD - now
SIENNAP LTD - 2019-06-18
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Intangible Assets
132,280 GBP2024-10-31
142,078 GBP2023-10-31
Property, Plant & Equipment
68,578 GBP2024-10-31
102,117 GBP2023-10-31
Investment Property
4,850,769 GBP2024-10-31
4,850,769 GBP2023-10-31
Fixed Assets
5,051,627 GBP2024-10-31
5,094,964 GBP2023-10-31
Debtors
1,268,260 GBP2024-10-31
405,868 GBP2023-10-31
Cash at bank and in hand
43,850 GBP2024-10-31
141,050 GBP2023-10-31
Current Assets
1,712,110 GBP2024-10-31
946,918 GBP2023-10-31
Net Current Assets/Liabilities
-1,240,133 GBP2024-10-31
-2,345,279 GBP2023-10-31
Total Assets Less Current Liabilities
3,811,494 GBP2024-10-31
2,749,685 GBP2023-10-31
Net Assets/Liabilities
2,650,436 GBP2024-10-31
2,704,338 GBP2023-10-31
Equity
Called up share capital
100 GBP2024-10-31
100 GBP2023-10-31
Retained earnings (accumulated losses)
2,650,336 GBP2024-10-31
2,704,238 GBP2023-10-31
Equity
2,650,436 GBP2024-10-31
2,704,338 GBP2023-10-31
Average Number of Employees
62023-11-01 ~ 2024-10-31
82022-05-01 ~ 2023-10-31
Intangible Assets - Gross Cost
Net goodwill
195,969 GBP2023-10-31
Intangible Assets - Accumulated Amortisation & Impairment
Net goodwill
63,689 GBP2024-10-31
53,891 GBP2023-10-31
Intangible Assets - Increase From Amortisation Charge for Year
Net goodwill
9,798 GBP2023-11-01 ~ 2024-10-31
Intangible Assets
Net goodwill
132,280 GBP2024-10-31
142,078 GBP2023-10-31
Property, Plant & Equipment - Gross Cost
Other
254,731 GBP2024-10-31
250,722 GBP2023-10-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
186,153 GBP2024-10-31
148,605 GBP2023-10-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
37,548 GBP2023-11-01 ~ 2024-10-31
Property, Plant & Equipment
Other
68,578 GBP2024-10-31
102,117 GBP2023-10-31
Investment Property - Fair Value Model
4,850,769 GBP2023-10-31
Other Debtors
Amounts falling due within one year
43,837 GBP2024-10-31
405,868 GBP2023-10-31
Amounts falling due after one year
1,224,423 GBP2024-10-31
0 GBP2023-10-31
Trade Creditors/Trade Payables
Current
2,076,384 GBP2024-10-31
2,470,040 GBP2023-10-31
Corporation Tax Payable
Current
148,810 GBP2024-10-31
206,937 GBP2023-10-31
Other Taxation & Social Security Payable
Current
45,409 GBP2024-10-31
105,033 GBP2023-10-31
Other Creditors
Current
681,640 GBP2024-10-31
510,187 GBP2023-10-31
Creditors
Current
2,952,243 GBP2024-10-31
3,292,197 GBP2023-10-31
Bank Borrowings/Overdrafts
Non-current
1,125,000 GBP2024-10-31
0 GBP2023-10-31
Other Creditors
Non-current
27,065 GBP2024-10-31
31,829 GBP2023-10-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
71,879 GBP2024-10-31
30,935 GBP2023-10-31

Related profiles found in government register
  • ALPHA PHARMACEUTICALS LTD
    Info
    DISPENSING PARTNERS LTD - 2019-07-18
    SIENNAP LTD - 2019-07-18
    Registered number 08467144
    Unit 7 Unit 7 Bondor Business Centre, London Road, Baldock, Herts SG7 6HP
    PRIVATE LIMITED COMPANY incorporated on 2013-03-28 (13 years 1 month). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-06-24
    CIF 0
  • ALPHA PHARMACEUTICALS LTD
    S
    Registered number 08467144
    Morningside Pharmacy, The Pines Surgery, Harborough Road North, Northampton, United Kingdom, NN2 8LL
    Private Limited Company in United Kingdom
    CIF 1
child relation
Offspring entities and appointments 1
  • 1
    ALPHA PHARMACEUTICALS PHARMA LTD
    16170374
    Northampton Pharmacy, Harborough Road North, Northampton, England
    Active Corporate (3 parents)
    Person with significant control
    2025-01-08 ~ now
    CIF 1 - Ownership of voting rights - More than 25% but not more than 50% OE
    CIF 1 - Ownership of shares – More than 25% but not more than 50% OE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.